Literature DB >> 12800163

Modulation of protein-protein interactions with small organic molecules.

Thorsten Berg1.   

Abstract

Many proteins exert their biological roles as components of complexes, and the functions of proteins are often determined by their specific interactions with other proteins. Because of the central importance of protein-protein interactions for cellular processes, the ability to interfere with specific protein-protein interactions provides a powerful means of influencing the function of selected proteins within the cell. Cell-permeable small organic modulators of protein-protein interactions are thus highly desirable tools both for the study of physiological cellular processes and for the treatment of numerous diseased states. Herein a number of protein-protein interactions that are considered to be pharmaceutical targets are presented, which will familiarize the reader with the strategies that have been employed for the successful identification of small molecule modulators of these protein-protein interactions. These encouraging examples suggest that combined research efforts in the areas of functional proteomics, assay development, and organic synthesis will open up novel possibilities for the treatment of human diseases in the future.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12800163     DOI: 10.1002/anie.200200558

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  64 in total

Review 1.  Evolution of immunity: no development without risk.

Authors:  Alexander B Sigalov
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  Effects of hypericin on the structure and aggregation properties of β-amyloid peptides.

Authors:  Emilia Bramanti; Francesco Lenci; Antonella Sgarbossa
Journal:  Eur Biophys J       Date:  2010-05-15       Impact factor: 1.733

3.  Identification of novel specific allosteric modulators of the glycine receptor using phage display.

Authors:  Megan E Tipps; Jessica E Lawshe; Andrew D Ellington; S John Mihic
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

Review 4.  Targeting protein-protein interactions for cancer therapy.

Authors:  David C Fry; Lyubomir T Vassilev
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

5.  Noncovalent modification of chymotrypsin surface using an amphiphilic polymer scaffold: implications in modulating protein function.

Authors:  Britto S Sandanaraj; Dharma Rao Vutukuri; Joseph M Simard; Akamol Klaikherd; Rui Hong; Vincent M Rotello; S Thayumanavan
Journal:  J Am Chem Soc       Date:  2005-08-03       Impact factor: 15.419

6.  Development of small molecules designed to modulate protein-protein interactions.

Authors:  Ye Che; Bernard R Brooks; Garland R Marshall
Journal:  J Comput Aided Mol Des       Date:  2006-04-19       Impact factor: 3.686

7.  Stabilizers of the Max homodimer identified in virtual ligand screening inhibit Myc function.

Authors:  Hao Jiang; Kristen E Bower; Albert E Beuscher; Bin Zhou; Andrey A Bobkov; Arthur J Olson; Peter K Vogt
Journal:  Mol Pharmacol       Date:  2009-06-04       Impact factor: 4.436

8.  Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.

Authors:  Béatrice Laudet; Caroline Barette; Vincent Dulery; Olivier Renaudet; Pascal Dumy; Alexandra Metz; Renaud Prudent; Alexandre Deshiere; Otto Dideberg; Odile Filhol; Claude Cochet
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

9.  Bcl-XL-templated assembly of its own protein-protein interaction modulator from fragments decorated with thio acids and sulfonyl azides.

Authors:  Xiangdong Hu; Jiazhi Sun; Hong-Gang Wang; Roman Manetsch
Journal:  J Am Chem Soc       Date:  2008-09-24       Impact factor: 15.419

10.  Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds.

Authors:  Giorgio Colombo; Barbara Margosio; Laura Ragona; Marco Neves; Silvia Bonifacio; Douglas S Annis; Matteo Stravalaci; Simona Tomaselli; Raffaella Giavazzi; Marco Rusnati; Marco Presta; Lucia Zetta; Deane F Mosher; Domenico Ribatti; Marco Gobbi; Giulia Taraboletti
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.